Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0004096,
umls-concept:C0015399,
umls-concept:C0022203,
umls-concept:C0040233,
umls-concept:C0458827,
umls-concept:C0681850,
umls-concept:C0728923,
umls-concept:C0871261,
umls-concept:C1550501,
umls-concept:C1704632,
umls-concept:C1706203,
umls-concept:C1706817,
umls-concept:C1707455,
umls-concept:C2349001,
umls-concept:C2697811,
umls-concept:C2911692
|
pubmed:issue |
4
|
pubmed:dateCreated |
1988-2-10
|
pubmed:abstractText |
1. The inadvertent administration of timolol to asthmatic patients continues to cause occasional severe and even fatal attacks of asthma. The (R)-enantiomer of timolol, L-714,465, is four times less potent than timolol in reducing intraocular pressure in man. It is 49 times less potent than timolol on beta 2-adrenoceptors in animals and 13 times less potent on the airways of normal subjects. These findings suggested that L-714,465 might be a safer alternative for the treatment of glaucoma. 2. Ten subjects with mild asthma who bronchoconstricted to timolol eye drops (0.25 or 0.5%) were studied. Airway dose-response curves to timolol (0-2%), L-714,465 (0-4%), and placebo (methyl cellulose) eye drops were performed in a double-blind randomised study in which airway response was measured as change in FEV1 and specific airway conductance (sGaw). 3. L-714,465 and timolol caused dose dependent falls in sGaw and FEV1 with L-714,465 being approximately four times less potent than timolol. The geometric mean dose ratio was 3.89 for FEV1 (95% confidence interval (CI) 1.7-8.7) and 3.93 (95% CI 2-7.8) for sGaw. Since the difference in potency is similar to the reported difference in potency of the two drugs on intraocular pressure we conclude that L-714,465 would not have a greater safety margin than timolol. 4. After completion of the dose-response study eight subjects inhaled ipratropium bromide (72 micrograms) and this caused an increase in FEV1 from 74% to 80% of baseline.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2961362-110183,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2961362-2866789,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2961362-3946922,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2961362-4076358,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2961362-4398175,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2961362-4866848,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2961362-6141730,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2961362-6493304,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2961362-7083757
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0306-5251
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
485-91
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:2961362-Adolescent,
pubmed-meshheading:2961362-Adult,
pubmed-meshheading:2961362-Aged,
pubmed-meshheading:2961362-Albuterol,
pubmed-meshheading:2961362-Asthma,
pubmed-meshheading:2961362-Bronchi,
pubmed-meshheading:2961362-Dose-Response Relationship, Drug,
pubmed-meshheading:2961362-Forced Expiratory Volume,
pubmed-meshheading:2961362-Humans,
pubmed-meshheading:2961362-Ipratropium,
pubmed-meshheading:2961362-Isomerism,
pubmed-meshheading:2961362-Middle Aged,
pubmed-meshheading:2961362-Ophthalmic Solutions,
pubmed-meshheading:2961362-Timolol
|
pubmed:year |
1987
|
pubmed:articleTitle |
Comparison of the airway response to eye drops of timolol and its isomer L-714,465 in asthmatic subjects.
|
pubmed:affiliation |
Medicine 1, Southampton General Hospital.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|